Antibody Production Market Size to Reach USD 59.1 Billion by 2032 with a CAGR of 13.2% as Per Acumen Research and Consulting
Acumen Research and Consulting recently published report titled “Antibody Production Market Forecast, 2023 – 2032”
LOS ANGELES, Aug. 25, 2023 (GLOBE NEWSWIRE) — The Antibody Production Market outlook remains positive, fueled by rising disease incidence, increasing pharma R&D investments, growing biotechnology research funding, and advancements in recombinant antibody technologies. This article provides a thorough antibody production market analysis including size, share, latest trends, drivers, challenges and key companies.
Antibodies are proteins produced by the body’s immune system to fight off infection. They are produced by B cells, which are a type of white blood cell. When a B cell encounters an antigen, such as a virus or bacteria, it produces antibodies that specifically bind to that antigen. This binding helps to neutralize the antigen and prevent it from causing infection. Antibodies are produced in the bone marrow. They are then released into the bloodstream, where they can circulate and bind to antigens. Antibodies can also be produced in the lymph nodes, spleen, and other organs. There are many different types of antibodies, each with a specific binding site. This allows the body to produce antibodies that can bind to a wide variety of antigens. Antibodies are an important part of the body’s immune system and help to protect the body from infection.
Antibody Production Market Statistics and Highlights:
- Antibody Production Market Size to hit USD 59.1 billion by 2032, expanding from the value of USD 17.3 Billion in the year 2022, progressing at a CAGR of 13.2% during 2023-2032.
- North America captured a dominant revenue share exceeding 39% in 2022.
- Based on product, the consumables segment accounted for over 56% share in 2022.
- Increasing development of antibody-based therapeutics is propelling the market growth.
Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/3322
Antibody Production Market Report Coverage:
| Market | Antibody Production Market | |
| Antibody Production Market Size 2022 | USD 17.3 Billion | |
| Antibody Production Market Forecast 2032 | USD 59.1 Billion | |
| Antibody Production Market CAGR During 2023 – 2032 | 13.2% | |
| Antibody Production Market Analysis Period | 2020 – 2032 | |
| Antibody Production Market Base Year | 2022 | |
| Antibody Production Market Forecast Data | 2023 – 2032 | |
| Segments Covered | By Product, By Process, By Type, By End-use, And By Geography | |
| Antibody Production Market Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa | |
| Key Companies Profiled | Thermo Fisher Scientific, Merck KGaA, Abcam, Bio-Rad Laboratories, GenScript, Lonza Group, Cell Signaling Technology, BioLegend, Agilent Technologies, Novus Biologicals, Proteintech Group, and Rockland Immunochemicals | |
| Report Coverage | Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis | |
Analysis of Key Antibody Production Market Dynamics:
The antibody production market is expected to grow at a significant rate in the coming years. This growth is being driven by a number of factors, including the rising incidence of chronic and infectious diseases, increased R&D investments in antibody research, growing public-private funding in life science research, and continuous improvements in recombinant antibody technologies. However, there are a number of challenges that could restrain the growth of the market. These include the availability of other non-antibody-based drug options, challenges in antibody humanization, and high overall production costs. Despite these challenges, the antibody production market is expected to remain upbeat in the coming years. This is due to the strong growth potential of the market, which is being driven by the factors mentioned above. In the future, the market is expected to be shaped by focus on transgenic animals and plants, biomarker discovery, and genetic engineering. These technologies are expected to help to improve the efficiency of antibody production and reduce the costs associated with it.
Latest Innovations and Trends:
- Transgenic animals and plants for more cost-efficient polyclonal antibody production.
- Leveraging nanobody and synthetic antibodies for higher antigen specificity.
- Advancements in purification resins and chromatography techniques.
- Integration of real-time analysis and process analytical technologies (PAT).
- Novel methods ensure greater antibody humanization.
Major Factors Driving Antibody Production Market Growth:
- Rising incidence of chronic diseases like cancer and neurological disorders globally.
- Increasing R&D investments in antibody therapeutics and diagnostics.
- Growing government funding for biotechnology research and genomics projects.
- Technology advancements in genetic engineering, purification, and manufacturing.
- Strong clinical pipeline comprising antibody candidates across major pharma companies.
Key Challenges Hindering Market Potential:
- Availability of non-antibody-based treatment approaches for certain diseases.
- Challenges related to antibody humanization and immunogenicity.
- High overall production costs owing to intensive resource requirements.
- Increasing filings of biosimilars upon patent expiry of blockbuster antibody drugs.
- Presence of alternative novel therapeutics like cell and gene therapies.
Check the detailed table of contents of the report @
https://www.acumenresearchandconsulting.com/table-of-content/antibody-production-market
Antibody Production Market Segmentation
Based on the Product
- Instrument
- Filtration systems
- Chromatography Systems
- Bioreactors
- Software
- Consumables
- Filtration Consumables and Accessories
- Media
- Buffers and Reagents
- Chromatography Resins and Columns
- Other
Based on the Process
- Upstream Processing
- Downstream Processing
Based on the Type
- Monoclonal Antibody
- Polyclonal Antibody
Based on the End-use
- Research Laboratories
- Pharmaceutical and Biotechnology Companies
- CROs and CDMOs
Antibody Production Market Regional Outlook:
North America leads the global antibody production market presently driven by expansive biopharma activity. Asia Pacific will exhibit the fastest growth during 2023-2032 owing to improving biomanufacturing infrastructure. Europe accounts for the second largest share currently.
Buy this premium research report –
https://www.acumenresearchandconsulting.com/buy-now/0/3322
Leading Companies Offering Antibody Production Services:
Major players include Thermo Fisher Scientific, Inc., GenScript Biotech Corp., Abcam plc, Merck KGaA, Sartorius AG, Rockland Immunochemicals, Inc., ProMab Biotechnologies, Inc., JSR Life Sciences, LLC, Envigo Laboratories, Inc., and Bio-Techne Corporation, among others.
Browse More Research Topic on Healthcare Sector Related Reports:
The Global Terrestrial Laser Scanning (TLS) Market Size accounted for USD 4.1 Billion in 2022 and is projected to achieve a market size of USD 8.3 Billion by 2032 growing at a CAGR of 7.4% from 2023 to 2032.
The Global Small Animal Imaging Market Size accounted for USD 986.2 Million in 2022 and is estimated to achieve a market size of USD 2,029.3 Million by 2032 growing at a CAGR of 7.6% from 2023 to 2032.
The Global Cell Culture Protein Surface Coating Market Size accounted for USD 805 Million in 2022 and is projected to achieve a market size of USD 3,145 Million by 2032 growing at a CAGR of 14.8% from 2023 to 2032.
Browse Our Official Website Press release:
https://www.acumenresearchandconsulting.com/press-releases/antibody-production-market
About Acumen Research and Consulting:
Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
For Latest Update Follow Us on Twitter , Instagram and LinkedIn
Contact Us:
Mr. Richard Johnson
Acumen Research and Consulting
USA: +13474743864
India: +918983225533
E-mail: [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. TheTechOutlook.com takes no editorial responsibility for the same. 